Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observer-blind, Multi-centre, Randomized, Parallel-group Study to Compare the Efficacy and Safety of Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

NCT03439436 is registered in ClinicalTrials.gov with McNeil AB as lead sponsor.

NCT NCT03439436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03439436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observer-blind, Multi-centre, Randomized, Parallel-group Study to Compare the Efficacy and Safety of Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
Lead sponsor
McNeil AB
Phase
Phase 3
Overall status
Completed
Start date
February 26, 2018
Completion date
May 2, 2018
Enrollment
140 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nasal congestion